1. LncRNA NEAT1 aggravates human microvascular endothelial cell injury by inhibiting the Apelin/Nrf2/HO-1 signalling pathway in type 2 diabetes mellitus with obstructive sleep apnoea
   Kai Chen et al, 2024, Epigenetics CrossRef
2. Macrophage lncRNAs in cancer development: Long-awaited therapeutic targets
   Imene Arab et al, 2023, Biochemical Pharmacology CrossRef
3. Molecular Mechanisms and Functions of lncRNAs in the Inflammatory Reaction of Diabetes Mellitus
   Linjuan Huang et al, 2021, International Journal of Endocrinology CrossRef
4. Interleukin-1β in Multifactorial Hypertension: Inflammation, Vascular Smooth Muscle Cell and Extracellular Matrix Remodeling, and Non-Coding RNA Regulation
   Elaina Melton et al, 2021, International Journal of Molecular Sciences CrossRef
5. A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signalling
   Djo Hasan et al, 2022, Purinergic Signalling CrossRef
6. Ultra-conserved RNA: a novel biological tool with diagnostic and therapeutic potential
   Tingye Wang et al, 2023, Discover Oncology CrossRef
7. Participation of lncRNAs in the development of diabetic complications: Systematic review and meta‐analysis. I. Rat
   Leonardo‐Elias Cabrera‐Najera et al, 2024, Diabetic Medicine CrossRef
8. Non‐coding RNAs in diabetic foot ulcer‐ a focus on infected wounds
   Boquan Qin et al, 2024, Diabetes/Metabolism Research and Reviews CrossRef